Here's What This "Market-Destroying" Investor Is Buying

Every quarter, many money managers have to disclose what they've bought and sold, via "13F" filings. Their latest moves can shine a bright light on smart stock picks.

Today, let's look at Joel Greenblatt's Gotham Asset Management. It's of great interest to many investors because Greenblatt is the author of the well-regarded and best-selling The Little Book That Beats the Market and because his system of seeking out companies with high returns on capital and hefty earnings yields. His "Magic Formula" has many fans. As my colleague Morgan Housel has noted, "The simple formula absolutely destroys market averages over time. Greenblatt backs this up with considerable statistical evidence."

The company's reportable stock portfolio totaled $2.3 billion in value as of June 30, 2013.

Interesting developments
So what does Gotham's latest quarterly 13F filing tell us? Here are a few interesting details:

The biggest new holdings are Salix Pharmaceuticals and Werner Enterprises. Other new holdings of interest include Pinnacle Foods (NYSE: PF  ) , a recent IPO with a strategy of "Reinvigorating Iconic Brands" and a new dividend, yielding about 2.6%. The company has a significant debt load, but it also has a strong brandlineup, featuring brands such as Birds Eye, Aunt Jemima, Hungry-Man, Van de Kamp's, Armour, Lender's, Mrs. Paul's, Vlasic, Log Cabin, Mrs. Butterworth, and Duncan Hines. It just bought Wish-Bone salad dressing for $580 million, too. In Pinnacle's second quarter, revenue dropped 3%, with management noting, "We delivered another quarter of strong earnings growth as we expanded gross margins through effective productivity programs and ongoing improvement in product mix."

Among holdings in which Gotham Asset Management increased its stake was Edwards Lifesciences (NYSE: EW  ) , a heart-valve maker. The stock got a boost recently when Japan announced that it would reimburse patients for Edwards's SAPIEN XT valves. The company's second quarter featured results that exceeded expectations on solid sales of its Sapien valve. Revenue rose 7%, while EPS surged 44%. It does face competition, though, such as from Medtronic, which is more than six times its size. Bulls like Edwards' devices permit the avoidance of more invasive procedures or open-heart surgeries.

Gotham Asset Management decreased its stake in Permian Basin Royalty Trust (NYSE: PBT  ) , which has seen its top and bottom lines shrink a bit in recent years. The stock yields 7.9%, though, is paid monthly, and has risen in recent years. Its fortunes are tied to energy-producing properties in Texas, and to the prices of oil and gas.

Finally, Gotham's biggest closed positions included MetroPCS Communications and Sauer-Danfoss. Other closed positions of interest include GT Advanced Technologies (NASDAQ: GTAT  ) and McDermott International (NYSE: MDR  ) . GTAT Advanced Technologies, in the solar energy business, has been the Nasdaq's most hated stock, heavily shorted due to struggling Chinese solar companies and pricing pressures. Shorts have been burned, though, with GTAT delivering surprisingly strong second-quarter results and boasting some promising technologies such as sapphire-based materials that could serve as screens in smartphones and elsewhere.

Oil and gas equipment and services company McDermott International took a big hit after it posted very weak second-quarter results, and its stock received several analyst downgrades. As the CEO noted, "As a management team, we are taking immediate and decisive actions to correct the weakness we have experienced in our project bidding and execution..." He added, "We are driving a more disciplined culture within the Company," and warned that, "problematic projects are expected to require some time to fully work through the system." Still, the company does have an order backlog of $5.1 billion and with a forward P/E of 12, some see value there.

We should never blindly copy any investor's moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing. 13-F forms can be great places to find intriguing candidates for our portfolios.

If you'd like another stock idea from another smart investor, The Motley Fool's chief investment officer has selected his No. 1 stock for this year, and you can learn all about it in the special free report: "The Motley Fool's Top Stock for 2013." Just click here to access the report and find out the name of this under-the-radar company.


Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 27, 2013, at 7:28 AM, rsinj wrote:

    MDR: So what we learned is that Gotham bought high and sold low - think of all the people kicking themselves for having followed when Greenblatt originally bought. You would have likely highlighted the purchase in this series of articles at the time - correct?

    Now, because Greenblatt sells at a loss there is some argument that investors follow the lead? That he was so right purchasing MDR previously, his decision to sell MDR shares at decade lows means others should take notice? Smarter investors can now buy low and sell high later courtesy of Greenblatt. If Greenblatt thought the shares were such a good investment at higher prices, surely they are a bargain now.

Add your comment.

DocumentId: 2610409, ~/Articles/ArticleHandler.aspx, 4/24/2014 2:28:35 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement